✕
1 — 3
TACHYON

Revolutionizing Medical Diagnostics and Treatment

Originally from edition.cnn.com

Tachyon by HQ Technologies is a revolutionary in-vitro point-of-care tool that utilizes advanced long-read sequencing and sophisticated bioinformatics to transform medical diagnostics and treatment. Developed by the British-German MedTech company HQ Science Ltd., and endorsed by global health and defense leaders, Tachyon delivers rapid, precise, and cost-effective genetic analysis directly from clinical samples.
This versatile device excels in various medical applications, from routine clinical care to emergency response. Its capability to quickly and accurately analyze genetic material makes it an invaluable asset in both personalized medicine and public health. By integrating cutting-edge technology with real-time data analysis, Tachyon is set to redefine how personalized diagnostics and treatments are conducted, paving the way for significant advancements in healthcare.

Key Technological Features

Speed and Efficiency:

Tachyon drastically reduces the time needed for gene sequencing and data analysis. It delivers results within hours, enabling healthcare providers to make rapid, informed decisions crucial for effective medical interventions.

Versatility:

This technology is adaptable for numerous medical applications, including oncology, genetics, and personalized medicine. Its universal application makes it invaluable in healthcare, research, and biotechnology sectors.

Artificial Intelligence:

Tachyon uses advanced AI algorithms for fast and precise data analysis. This enhances the efficiency of diagnostics, providing detailed insights that inform personalized treatment plans tailored to individual patients.

High Sample Throughput:

Designed to process multiple samples simultaneously, Tachyon increases the capacity for high-throughput sequencing. This significantly cuts down overall processing time, making it ideal for settings requiring rapid turnaround.

Cost-Efficiency:

By streamlining sequencing processes and cutting analysis times, Tachyon lowers the costs associated with genetic diagnostics, making advanced medical technology more accessible and affordable.

Use Cases

Radiation Preparedness - Radiological Emergency Response:

Tachyon Guardian, a specialized version of the device, is pivotal in radiological emergency preparedness. In collaboration with the UK Health Security Agency (UKHSA), Tachyon is going to integrated into the UK's emergency protocols. It can rapidly assess radiation exposure in blood samples, reducing response times from days to hours. This capability greatly enhances the efficiency of emergency triage and national response strategies.

Oncoradio DX - Personalized Radiation Oncology:

In radiation oncology, Tachyon provides highly personalized diagnostics by tailoring radiation therapy to each patient’s genetic profile. It optimizes dosing to maximize treatment efficacy and minimize side effects. Tachyon’s rapid, real-time analysis of molecular data allows for immediate adjustments to treatment plans, significantly improving clinical outcomes and ensuring precise, effective radiation therapy.

Antimicrobial Resistance (AMR) - Combatting AMR:

Tachyon is adept at addressing antimicrobial resistance (AMR) by rapidly sequencing pathogen genomes and detecting resistance genes and mutations. This detailed genetic mapping offers critical insights into the pathogen’s capabilities, guiding immediate clinical responses. Tachyon’s comprehensive analysis extends to plasmids and genetic elements that spread resistance, enabling personalized antimicrobial therapy and supporting efforts to monitor and control resistant pathogens.

Pathogen Detection - Advanced Pathogen Identification:

Tachyon revolutionizes pathogen detection by decoding entire genomes of bacteria, viruses, or fungi directly from clinical samples. This allows for the swift and accurate identification of pathogens, including closely related strains. The device provides detailed genetic insights into pathogen behavior, such as virulence factors and resistance genes, which are crucial for developing targeted and effective treatment strategies.

Sepsis Management - Transformative Sepsis Care:

In managing sepsis, a critical condition caused by the body’s response to infection, Tachyon's rapid sequencing capabilities are vital. It quickly identifies a wide range of pathogens from a patient’s blood, facilitating the timely initiation of appropriate treatment and improving survival rates. Beyond pathogen identification, Tachyon provides insights into resistance genes, allowing for precise tailoring of antimicrobial therapy. Its real-time data processing produces actionable reports, enabling quick and informed clinical decisions that enhance sepsis management and reduce the risk of complications and mortality.

Tachyon workflow

Photo by Daniel Olah on Unsplash

Photo by Minimography on Pexels

1 — 3
TACHYON

Revolutionizing Medical Diagnostics and Treatment

Originally from edition.cnn.com

Tachyon by HQ Technologies is a revolutionary in-vitro point-of-care tool that utilizes advanced long-read sequencing and sophisticated bioinformatics to transform medical diagnostics and treatment. Developed by the British-German MedTech company HQ Science Ltd., and endorsed by global health and defense leaders, Tachyon delivers rapid, precise, and cost-effective genetic analysis directly from clinical samples.
This versatile device excels in various medical applications, from routine clinical care to emergency response. Its capability to quickly and accurately analyze genetic material makes it an invaluable asset in both personalized medicine and public health. By integrating cutting-edge technology with real-time data analysis, Tachyon is set to redefine how personalized diagnostics and treatments are conducted, paving the way for significant advancements in healthcare.

Key Technological Features

Speed and Efficiency:

Tachyon drastically reduces the time needed for gene sequencing and data analysis. It delivers results within hours, enabling healthcare providers to make rapid, informed decisions crucial for effective medical interventions.

Versatility:

This technology is adaptable for numerous medical applications, including oncology, genetics, and personalized medicine. Its universal application makes it invaluable in healthcare, research, and biotechnology sectors.

Artificial Intelligence:

Tachyon uses advanced AI algorithms for fast and precise data analysis. This enhances the efficiency of diagnostics, providing detailed insights that inform personalized treatment plans tailored to individual patients.

High Sample Throughput:

Designed to process multiple samples simultaneously, Tachyon increases the capacity for high-throughput sequencing. This significantly cuts down overall processing time, making it ideal for settings requiring rapid turnaround.

Cost-Efficiency:

By streamlining sequencing processes and cutting analysis times, Tachyon lowers the costs associated with genetic diagnostics, making advanced medical technology more accessible and affordable.

Use Cases

Radiation Preparedness - Radiological Emergency Response:

Tachyon Guardian, a specialized version of the device, is pivotal in radiological emergency preparedness. In collaboration with the UK Health Security Agency (UKHSA), Tachyon is going to integrated into the UK's emergency protocols. It can rapidly assess radiation exposure in blood samples, reducing response times from days to hours. This capability greatly enhances the efficiency of emergency triage and national response strategies.

Oncoradio DX - Personalized Radiation Oncology:

In radiation oncology, Tachyon provides highly personalized diagnostics by tailoring radiation therapy to each patient’s genetic profile. It optimizes dosing to maximize treatment efficacy and minimize side effects. Tachyon’s rapid, real-time analysis of molecular data allows for immediate adjustments to treatment plans, significantly improving clinical outcomes and ensuring precise, effective radiation therapy.

Antimicrobial Resistance (AMR) - Combatting AMR:

Tachyon is adept at addressing antimicrobial resistance (AMR) by rapidly sequencing pathogen genomes and detecting resistance genes and mutations. This detailed genetic mapping offers critical insights into the pathogen’s capabilities, guiding immediate clinical responses. Tachyon’s comprehensive analysis extends to plasmids and genetic elements that spread resistance, enabling personalized antimicrobial therapy and supporting efforts to monitor and control resistant pathogens.

Pathogen Detection - Advanced Pathogen Identification:

Tachyon revolutionizes pathogen detection by decoding entire genomes of bacteria, viruses, or fungi directly from clinical samples. This allows for the swift and accurate identification of pathogens, including closely related strains. The device provides detailed genetic insights into pathogen behavior, such as virulence factors and resistance genes, which are crucial for developing targeted and effective treatment strategies.

Sepsis Management - Transformative Sepsis Care:

In managing sepsis, a critical condition caused by the body’s response to infection, Tachyon's rapid sequencing capabilities are vital. It quickly identifies a wide range of pathogens from a patient’s blood, facilitating the timely initiation of appropriate treatment and improving survival rates. Beyond pathogen identification, Tachyon provides insights into resistance genes, allowing for precise tailoring of antimicrobial therapy. Its real-time data processing produces actionable reports, enabling quick and informed clinical decisions that enhance sepsis management and reduce the risk of complications and mortality.

Temporary hunting alliances between octopuses and coral reef fish have been documented for decades and can involve multiple participants of various species, the study authors reported Dec. 18 in the journal Ecology. Sometimes, fish and octopuses will work together for more than an hour, with different species scouting different locations. Octopuses pursue prey that dart around rocks and into tight spaces in the reef, while bottom-feeding fish such as the yellow-saddle goatfish (Parupeneus cyclostomus) scour the seafloor, and other fish species patrol the water column, according to the study.

Read full Article
GeoSpace • Free Webflow HTML website template • 2021 • By JP
✕
2 — 3
ABOUT US

History of HQ Science Ltd.

HQ Science Ltd., founded by oncologist Stanislav Polozov, excels in personalized molecular diagnostics and innovative treatments. With a strong foundation in Stan’s expertise from fellowships at the Grigoriev Institute in Kharkiv and the UK Health Security Agency (UKHSA) in Harwell-Oxford, the company has pioneered significant advancements. Stan’s work at UKHSA on rapid gene expression-based dose estimation during radiological emergencies underscored the need for swift, personalized medical responses. This experience spurred the creation of the Tachyon Device, a versatile tool combining long-read sequencing with AI for real-time, personalized molecular diagnostics. The Tachyon Device's adaptability extends beyond oncology to various fields like genetics and infectious disease management, providing tailored insights and enhancing treatment efficacy. HQ Science is committed to advancing radiation preparedness and personalized medicine, making cutting-edge diagnostics and treatments globally accessible.

TEAM

Stanislav Polozov

Stanislav Polozov, CEO of HQ Science, is a seasoned oncologist with a rich background in medical education and clinical oncology. Coming from a lineage of six generations of doctors, Stan’s expertise in radiation therapy and cancer complexities drives his mission to integrate advanced technologies into medical practice. Leading the development of the Tachyon Device at HQ Science, he has created a tool that not only revolutionizes cancer care but also adapts to various medical fields, from genetics to infectious diseases. The device uses long-read sequencing and AI to deliver personalized diagnostics by analyzing each patient’s genetic profile, enabling precise and effective treatments. Known for his global outreach, Stan has built partnerships with top research institutions and healthcare organizations, enhancing the understanding and application of molecular diagnostics. Under his guidance, HQ Science aims to make advanced diagnostic and therapeutic technologies accessible worldwide, catering to diverse medical needs.

Dr Veronica Goriacha

Lorem ipsum dolor sit amet. Quo galisum maxime aut ratione galisum eos fugiat internos qui quam tempora sit ipsa aperiam aut molestiae galisum. Aut internos voluptas sed ducimus quam est odio perferendis non suscipit voluptatem et unde dicta vel adipisci incidunt est unde fuga. In facere perferendis ad praesentium modi eum voluptates eius cum officiis quos et autem ducimus.

Maria Polozov

Lorem ipsum dolor sit amet. Quo galisum maxime aut ratione galisum eos fugiat internos qui quam tempora sit ipsa aperiam aut molestiae galisum. Aut internos voluptas sed ducimus quam est odio perferendis non suscipit voluptatem et unde dicta vel adipisci incidunt est unde fuga. In facere perferendis ad praesentium modi eum voluptates eius cum officiis quos et autem ducimus.

Paul

Lorem ipsum dolor sit amet. Quo galisum maxime aut ratione galisum eos fugiat internos qui quam tempora sit ipsa aperiam aut molestiae galisum. Aut internos voluptas sed ducimus quam est odio perferendis non suscipit voluptatem et unde dicta vel adipisci incidunt est unde fuga. In facere perferendis ad praesentium modi eum voluptates eius cum officiis quos et autem ducimus.

‍

Adviser

Steffen Irrgang

Lorem ipsum dolor sit amet. Quo galisum maxime aut ratione galisum eos fugiat internos qui quam tempora sit ipsa aperiam aut molestiae galisum. Aut internos voluptas sed ducimus quam est odio perferendis non suscipit voluptatem et unde dicta vel adipisci incidunt est unde fuga. In facere perferendis ad praesentium modi eum voluptates eius cum officiis quos et autem ducimus.

Katerina Irrgang

Lorem ipsum dolor sit amet. Quo galisum maxime aut ratione galisum eos fugiat internos qui quam tempora sit ipsa aperiam aut molestiae galisum. Aut internos voluptas sed ducimus quam est odio perferendis non suscipit voluptatem et unde dicta vel adipisci incidunt est unde fuga. In facere perferendis ad praesentium modi eum voluptates eius cum officiis quos et autem ducimus.

Dr. Christoph Badie

Lorem ipsum dolor sit amet. Quo galisum maxime aut ratione galisum eos fugiat internos qui quam tempora sit ipsa aperiam aut molestiae galisum. Aut internos voluptas sed ducimus quam est odio perferendis non suscipit voluptatem et unde dicta vel adipisci incidunt est unde fuga. In facere perferendis ad praesentium modi eum voluptates eius cum officiis quos et autem ducimus.

Dr. Lourdes

Lorem ipsum dolor sit amet. Quo galisum maxime aut ratione galisum eos fugiat internos qui quam tempora sit ipsa aperiam aut molestiae galisum. Aut internos voluptas sed ducimus quam est odio perferendis non suscipit voluptatem et unde dicta vel adipisci incidunt est unde fuga. In facere perferendis ad praesentium modi eum voluptates eius cum officiis quos et autem ducimus.

Collaborator

UKHSA

Lorem ipsum dolor sit amet. Quo galisum maxime aut ratione galisum eos fugiat internos qui quam tempora sit ipsa aperiam aut molestiae galisum. Aut internos voluptas sed ducimus quam est odio perferendis non suscipit voluptatem et unde dicta vel adipisci incidunt est unde fuga. In facere perferendis ad praesentium modi eum voluptates eius cum officiis quos et autem ducimus.

Lille

Lorem ipsum dolor sit amet. Quo galisum maxime aut ratione galisum eos fugiat internos qui quam tempora sit ipsa aperiam aut molestiae galisum. Aut internos voluptas sed ducimus quam est odio perferendis non suscipit voluptatem et unde dicta vel adipisci incidunt est unde fuga. In facere perferendis ad praesentium modi eum voluptates eius cum officiis quos et autem ducimus.

Norway

Lorem ipsum dolor sit amet. Quo galisum maxime aut ratione galisum eos fugiat internos qui quam tempora sit ipsa aperiam aut molestiae galisum. Aut internos voluptas sed ducimus quam est odio perferendis non suscipit voluptatem et unde dicta vel adipisci incidunt est unde fuga. In facere perferendis ad praesentium modi eum voluptates eius cum officiis quos et autem ducimus.

GIMRO

Lorem ipsum dolor sit amet. Quo galisum maxime aut ratione galisum eos fugiat internos qui quam tempora sit ipsa aperiam aut molestiae galisum. Aut internos voluptas sed ducimus quam est odio perferendis non suscipit voluptatem et unde dicta vel adipisci incidunt est unde fuga. In facere perferendis ad praesentium modi eum voluptates eius cum officiis quos et autem ducimus.

Colombia

Lorem ipsum dolor sit amet. Quo galisum maxime aut ratione galisum eos fugiat internos qui quam tempora sit ipsa aperiam aut molestiae galisum. Aut internos voluptas sed ducimus quam est odio perferendis non suscipit voluptatem et unde dicta vel adipisci incidunt est unde fuga. In facere perferendis ad praesentium modi eum voluptates eius cum officiis quos et autem ducimus.

✕
3 — 3
Bioinformatics

Bioinformatics Services at HQ Science Ltd.

HQ Science Ltd. provides cutting-edge bioinformatics services that revolutionize molecular diagnostics and personalized medicine. Central to these services is the automation of complex data analysis, enabling efficient handling of large genomic and transcriptomic datasets. With intuitive 'one-click' solutions, HQ Science empowers healthcare providers and researchers to quickly produce accurate diagnostic and scientific reports, minimizing human error and speeding up workflows for clinical and research applications.

A highlight of HQ Science's innovations is their point-of-care RNA-seq device. This advanced tool combines real-time data analysis with immediate clinical application, delivering rapid and precise diagnostics. The RNA-seq device processes RNA sequences swiftly, offering critical insights for both emergency responses and routine clinical care. Its broad application ranges from identifying cancer genetic markers to exploring gene expression in research, making it a crucial tool in personalized medicine.

HQ Science enhances its services with robust cloud-based platforms for secure, scalable, and accessible data storage and analysis. These cloud services ensure data security through encryption and allow flexible access, promoting better collaboration and operational efficiency. The scalable infrastructure adapts to the needs of organizations of all sizes, providing a cost-effective solution for startups and large research centers alike.

Beyond technology, HQ Science is dedicated to personalized support and customization. Their expert team offers tailored consultation and technical support to meet specific client needs. Whether it’s optimizing data workflows or providing user training, HQ Science ensures clients can maximize their bioinformatics capabilities. This comprehensive approach helps healthcare and research sectors make significant strides in molecular diagnostics and personalized medicine, advancing the future of precision healthcare.

This startup wants to build VR headsets with 'human eye-resolution'

Photo by Tima Miroshnichenko from Pexels

Photo by Artem Podrez from Pexels

Photo by Ivan Samkov from Pexels

Why show off this tech now? Largely because the company is currently raising cash stateside and was just awarded a few patents related to these technologies last week.I had the chance to demo a prototype of the company’s technology last week using a modified Oculus Rift headset with Varjo’s display systems embedded.I suppose the best testament to the company’s technology was that I spent most of the demo questioning whether my eye sight had actually been improved. After being dropped into an apartment scene, I was almost disturbed by my ability to read the spines of books on bookshelves several feet away.

Read full Article
GeoSpace • Free Webflow HTML website template • 2021 • By JP

TACHYON

About us

Bioinformatics

✕
1 — 3
TACHYON

Revolutionizing Medical Diagnostics and Treatment

Originally from edition.cnn.com

Tachyon by HQ Technologies is a revolutionary in-vitro point-of-care tool that utilizes advanced long-read sequencing and sophisticated bioinformatics to transform medical diagnostics and treatment. Developed by the British-German MedTech company HQ Science Ltd., and endorsed by global health and defense leaders, Tachyon delivers rapid, precise, and cost-effective genetic analysis directly from clinical samples.
This versatile device excels in various medical applications, from routine clinical care to emergency response. Its capability to quickly and accurately analyze genetic material makes it an invaluable asset in both personalized medicine and public health. By integrating cutting-edge technology with real-time data analysis, Tachyon is set to redefine how personalized diagnostics and treatments are conducted, paving the way for significant advancements in healthcare.

Key Technological Features

Speed and Efficiency:

Tachyon drastically reduces the time needed for gene sequencing and data analysis. It delivers results within hours, enabling healthcare providers to make rapid, informed decisions crucial for effective medical interventions.

Versatility:

This technology is adaptable for numerous medical applications, including oncology, genetics, and personalized medicine. Its universal application makes it invaluable in healthcare, research, and biotechnology sectors.

Artificial Intelligence:

Tachyon uses advanced AI algorithms for fast and precise data analysis. This enhances the efficiency of diagnostics, providing detailed insights that inform personalized treatment plans tailored to individual patients.

High Sample Throughput:

Designed to process multiple samples simultaneously, Tachyon increases the capacity for high-throughput sequencing. This significantly cuts down overall processing time, making it ideal for settings requiring rapid turnaround.

Cost-Efficiency:

By streamlining sequencing processes and cutting analysis times, Tachyon lowers the costs associated with genetic diagnostics, making advanced medical technology more accessible and affordable.

Use Cases

Radiation Preparedness - Radiological Emergency Response:

Tachyon Guardian, a specialized version of the device, is pivotal in radiological emergency preparedness. In collaboration with the UK Health Security Agency (UKHSA), Tachyon is going to integrated into the UK's emergency protocols. It can rapidly assess radiation exposure in blood samples, reducing response times from days to hours. This capability greatly enhances the efficiency of emergency triage and national response strategies.

Oncoradio DX - Personalized Radiation Oncology:

In radiation oncology, Tachyon provides highly personalized diagnostics by tailoring radiation therapy to each patient’s genetic profile. It optimizes dosing to maximize treatment efficacy and minimize side effects. Tachyon’s rapid, real-time analysis of molecular data allows for immediate adjustments to treatment plans, significantly improving clinical outcomes and ensuring precise, effective radiation therapy.

Antimicrobial Resistance (AMR) - Combatting AMR:

Tachyon is adept at addressing antimicrobial resistance (AMR) by rapidly sequencing pathogen genomes and detecting resistance genes and mutations. This detailed genetic mapping offers critical insights into the pathogen’s capabilities, guiding immediate clinical responses. Tachyon’s comprehensive analysis extends to plasmids and genetic elements that spread resistance, enabling personalized antimicrobial therapy and supporting efforts to monitor and control resistant pathogens.

Pathogen Detection - Advanced Pathogen Identification:

Tachyon revolutionizes pathogen detection by decoding entire genomes of bacteria, viruses, or fungi directly from clinical samples. This allows for the swift and accurate identification of pathogens, including closely related strains. The device provides detailed genetic insights into pathogen behavior, such as virulence factors and resistance genes, which are crucial for developing targeted and effective treatment strategies.

Sepsis Management - Transformative Sepsis Care:

In managing sepsis, a critical condition caused by the body’s response to infection, Tachyon's rapid sequencing capabilities are vital. It quickly identifies a wide range of pathogens from a patient’s blood, facilitating the timely initiation of appropriate treatment and improving survival rates. Beyond pathogen identification, Tachyon provides insights into resistance genes, allowing for precise tailoring of antimicrobial therapy. Its real-time data processing produces actionable reports, enabling quick and informed clinical decisions that enhance sepsis management and reduce the risk of complications and mortality.

Tachyon workflow

Photo by Daniel Olah on Unsplash

Photo by Minimography on Pexels

Unlock end-to-end molecular diagnostics at the point-of-care

Originally from edition.cnn.com

Tachyon is a cutting-edge point-of-care molecular diagnostics device that integrates nanopore sequencing with real-time gene expression analysis.  
15x faster, 2x cheaper. By delivering real-time results directly at the point of care and eliminating the need for off-site processing or specialised bioinformatics expertise, Tachyon reduces diagnostic turnaround times from weeks to under 24 hours. This innovation positions us at the forefront of precision medicine, offering significant value through enhanced efficiency, cost-effectiveness, and advancement in patient-centric care.

Key Technological Features

Rapid Results and Efficiency:

Tachyon significantly reduces the time required for gene sequencing and data analysis, delivering results within minutes to hours. This enables healthcare providers to make rapid, informed decisions crucial for effective medical interventions.

Versatile Applications:

Adaptable for numerous medical applications, including oncology, genetics, and personalised medicine, Tachyon's universal application makes it invaluable in healthcare, research, and biotechnology sectors.

Advanced Artificial Intelligence:

Advanced AI algorithms in Tachyon ensure fast and precise data analysis, enhancing diagnostic efficiency and providing detailed insights for personalised treatment plans tailored to individual patients.

High Sample Throughput:

Designed for high-throughput sequencing, Tachyon processes multiple samples simultaneously, significantly reducing overall processing time and making it ideal for settings requiring rapid turnaround.

Cost-Effective Solutions:

By streamlining sequencing processes and reducing analysis times, Tachyon lowers the costs associated with sequencing-based diagnostics, making advanced personalised diagnostics more accessible and affordable.

Use Cases

Personalised Diagnostics in Oncology:

HQ Science is ushering in a new era of point-of-care, patient-centric, and decentralised personalised diagnostics with our innovative Tachyon platform. Successfully developed and validated for radiation protection applications, Tachyon now transforms clinical oncology by delivering real-time, actionable insights tailored to each patient’s unique molecular profile. This breakthrough enhances treatment accuracy and responsiveness, empowering clinicians to provide truly personalised care.

Radiation Preparedness and Emergency Response:

Tachyon is a portable, point-of-care molecular diagnostic device designed to provide actionable insights during large-scale radiation incidents. By integrating nanopore sequencing technology with advanced algorithms for real-time bioinformatics analysis and biological dose assessment, Tachyon enables rapid and accurate evaluation of an individual’s radiation exposure status.

Innovative Infectious Disease Solutions:

Tachyon is transforming infectious disease management with advanced genetic analysis, delivering rapid, comprehensive insights directly from clinical samples. By decoding entire pathogen genomes, Tachyon enables accurate identification of a broad range of bacteria, viruses, and fungi. This precision-led approach allows for an in-depth understanding of pathogen characteristics, including factors influencing severity and potential treatment responses.

Temporary hunting alliances between octopuses and coral reef fish have been documented for decades and can involve multiple participants of various species, the study authors reported Dec. 18 in the journal Ecology. Sometimes, fish and octopuses will work together for more than an hour, with different species scouting different locations. Octopuses pursue prey that dart around rocks and into tight spaces in the reef, while bottom-feeding fish such as the yellow-saddle goatfish (Parupeneus cyclostomus) scour the seafloor, and other fish species patrol the water column, according to the study.

Read full Article
GeoSpace • Free Webflow HTML website template • 2021 • By JP
✕

About HQ Science

HQ Science Limited is a UK-based MedTech company specialising in the development of decentralised, point-of-care personalised molecular diagnostics. Our solutions empower healthcare professionals to perform advanced diagnostic testing without the need for specialised laboratories or highly trained bioinformatics personnel.

Leveraging the capabilities of our Tachyon platform, we provide rapid and accurate results directly within clinical settings, enhancing efficiency and patient care. Our commitment to accessibility and precision positions us at the forefront of medical diagnostics, supporting healthcare workers in delivering optimal outcomes.

TEAM

Stanislav Polozov

Stanislav Polozov, CEO of HQ Science, is a seasoned oncologist with a rich background in medical education and clinical oncology. Coming from a lineage of six generations of doctors, Stan’s expertise in radiation therapy and cancer complexities drives his mission to integrate advanced technologies into medical practice. Leading the development of the Tachyon Device at HQ Science, he has created a tool that not only revolutionizes cancer care but also adapts to various medical fields, from genetics to infectious diseases. The device uses long-read sequencing and AI to deliver personalized diagnostics by analyzing each patient’s genetic profile, enabling precise and effective treatments. Known for his global outreach, Stan has built partnerships with top research institutions and healthcare organizations, enhancing the understanding and application of molecular diagnostics. Under his guidance, HQ Science aims to make advanced diagnostic and therapeutic technologies accessible worldwide, catering to diverse medical needs.

Maria Polozova

Maria Polozova, a Research Officer at HQ Science, is a biomedical scientist with a degree in medicine (Clinical Immunologist, M.D.). She has extensive experience in clinical immunology and molecular biology, gained from her work at the Grigoriev Institute for Medical Radiology and Oncology (GIMRO) and a MELODI-granted fellowship, during which she further honed her skills in molecular biology laboratory techniques.

Veronica Goriacha

Veronica Goriacha, a Bioinformatician and Data Scientist at HQ Science, holds an M.Sc. in Applied Mathematics from Nikolay Zhukovskiy National Aerospace University (NZNAU) and a PhD in applying informatics, machine learning, and neural networks in medical data analysis. Her PhD focused on AI-driven analysis of clinical data to support diagnostics and disease staging in prostate cancer patients, conducted in collaboration with the Grigoriev Institute for Radiology and Oncology.

Paul Stetsenko

Paul is a results-driven IT professional with extensive experience in database administration, business continuity, cloud security, compliance, and seamless cloud migrations. His technical expertise spans Microsoft SQL Server deployment, administration, and automation, as well as disaster recovery and high availability planning. Paul is skilled in designing and migrating architectures on Amazon Web Services and Azure, with a strong focus on cloud security and Blockchain technology.

‍

Collaborator
✕

Automation and Decentralisation in Bioinformatics

With extensive expertise in molecular biology research — including genomics, transcriptomics, and epitranscriptomics — and a proven track record in designing fully automated, decentralised devices and software, we provide cutting-edge solutions for stakeholders in research and biotechnology.

At the forefront of our innovations is a point-of-care RNA-seq device, designed to deliver immediate, actionable insights. This device performs real-time RNA sequence analysis, providing essential data for emergency and routine clinical care. Its versatility extends across applications, from identifying cancer biomarkers to exploring gene expression in research, establishing it as an invaluable tool in personalised medicine. HQ Science combines technical innovation with tailored support to empower clients in achieving break throughs in molecular diagnostics and precision healthcare.

Our product

About us

Our services